Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.
FAQs
Kroger Company (KR) Stock Forecast, Price Targets and Analysts Predictions - TipRanks.com? ›
KR Stock 12 Month Forecast
What is the target price for KR? ›| High | $70.00 |
|---|---|
| Median | $59.00 |
| Low | $48.00 |
| Average | $58.75 |
| Current Price | $55.91 |
Based on short-term price targets offered by 15 analysts, the average price target for Kroger comes to $59.97. The forecasts range from a low of $50.00 to a high of $72.00. The average price target represents an increase of 8.64% from the last closing price of $55.20.
Is Kroger a good investment right now? ›KR is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock is trading with P/E ratio of 12.72 right now. For comparison, its industry sports an average P/E of 23.74. Over the past year, KR's Forward P/E has been as high as 12.75 and as low as 9.49, with a median of 10.46.
What is the financial projection for Kroger? ›Kroger is forecast to grow earnings and revenue by 8.8% and 1.4% per annum respectively. EPS is expected to grow by 10.3% per annum. Return on equity is forecast to be 19% in 3 years.
What is Kroger stock price forecast for 2025? ›On average, Wall Street analysts predict that Kroger Co's share price could reach $59.30 by Sep 9, 2025. The average Kroger Co stock price prediction forecasts a potential upside of 13.38% from the current KR share price of $52.30.
How often does KR pay dividends? ›( KR ) pays dividends on a quarterly basis. The Kroger Co.
What is Kroger projection for 2024? ›For fiscal 2024, the company continues to expect adjusted earnings of $4.30 to $4.50 per share. Analysts on average expect the company to report earnings of $4.44 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
What is Kroger future outlook? ›We now expect identical sales without fuel to be in the range of 0.75% to 1.75%. Our positive customer trends are driving sales momentum that we expect to continue in the second half of the year."
Who owns the most stock in Kroger? ›Who owns the most shares of Kroger Company (KR)? Vanguard owns the most shares of Kroger Company (KR).
Is Kroger a good dividend stock? ›
Dividend Yield vs Market
Notable Dividend: KR's dividend (2.45%) is higher than the bottom 25% of dividend payers in the US market (1.48%). High Dividend: KR's dividend (2.45%) is low compared to the top 25% of dividend payers in the US market (4.42%).
Compared to its competitors like Walmart and Costco, Kroger is relatively affordable. Its price-to-earnings ratio remains below the S&P 500 average, suggesting it could still be undervalued.
Is Kroger a strong company? ›Kroger has seen some strong revenue growth over the past decade. In the annual report released in 2015, KR had $108.5 billion in sales. That number was slightly north of $150 billion in the last annual report. The biggest growth took place between 2020 and 2023.
What are the analysts saying about Kroger stock? ›Analyst Price Targets
Based on analysts offering 12 month price targets for KR in the last 3 months. The average price target is $58.8 with a high estimate of $70 and a low estimate of $50.
KR Stock 12 Month Forecast
Based on 12 Wall Street analysts offering 12 month price targets for Kroger Company in the last 3 months. The average price target is $58.80 with a high forecast of $70.00 and a low forecast of $50.00. The average price target represents a 14.17% change from the last price of $51.50.
Kroger's merger with Albertsons will allow it to attract and retain more customers by lowering prices, creating a more seamless and personalized experience and expanding its selection of fresh, affordable food.
What is KRO price target? ›| Ticker | Price | Price Target |
|---|---|---|
| KRO | $11.56 | $11.67 |
| WTTR | $11.53 | $13.75 |
| NGVT | $39.53 | $50.00 |
| OEC | $18.65 | $23.00 |
| High | $12.57 |
|---|---|
| Low | $6.80 |
| Average | $10.71 |
| Current Price | $9.02 |
The average price target for Arrowhead Pharmaceuticals is $42.63. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $62.00 ,the lowest forecast is $20.00.
What is the price target price? ›A target price is an estimate of the future price of a stock. Target prices are based on earnings forecasts and assumed valuation multiples. Target prices can be used to evaluate stocks and may be even more useful than an equity analyst's rating.